Robert E. Gerl
Impact in
- Toxicology top 10%
-
- Cell death mechanisms and regulation
- Melanoma and MAPK Pathways
- RNA Interference and Gene Delivery
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- Cell death mechanisms and regulation 4
- Melanoma and MAPK Pathways 2
- Oncology 3
- Cancer-related Molecular Pathways 2
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- John W. Schrader (2 shared papers)Xuecui Guo (1 shared paper)John Silke (3 shared papers)Paul G. Ekert (2 shared papers)David L. Vaux (3 shared papers)Hitto Kaufmann (2 shared papers)Sharad Kumar (1 shared paper)Stuart H. Read (2 shared papers)
In The Last Decade
Robert E. Gerl
7 papers receiving 689 citations
Peers
Comparison fields: 5 of 98
- Toxicology 26
- Molecular Biology 447
- Immunology 114
- Cancer Research 76
- Oncology 134
Countries citing papers authored by Robert E. Gerl
This map shows the geographic impact of Robert E. Gerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Gerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Gerl more than expected).
Fields of papers citing papers by Robert E. Gerl
This network shows the impact of papers produced by Robert E. Gerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Gerl. The network helps show where Robert E. Gerl may publish in the future.
Co-authors
The 16 scholars most cited alongside Robert E. Gerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 329 | |
| 2 | 2004 | 146 | |
| 3 | 1998 | 85 | |
| 4 | 2003 | 67 | |
| 5 | 2000 | 49 | |
| 6 | 2008 | 24 | |
| 7 | 2005 | 1 | |
| 8 | Apaf-1, Caspase-2 and Caspase-9 accelerate apoptosis, but do not determine whether factor-deprived cells die | 2004 | 0 |
About Robert E. Gerl
Robert E. Gerl is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Immunology and Surgery, having authored 8 papers that have together received 701 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Phagocytosis and Immune Regulation (2 papers), Cancer-related Molecular Pathways (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer Mechanisms and Therapy (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), NF-κB Signaling Pathways (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Toxicology (26 citations), Molecular Biology (447 citations), Immunology (114 citations), Cancer Research (76 citations) and Oncology (134 citations). Robert E. Gerl has collaborated with scholars based in Australia and Canada. Frequent co-authors include John W. Schrader, Xuecui Guo, John Silke, Paul G. Ekert, David L. Vaux, Hitto Kaufmann, Sharad Kumar, Stuart H. Read, Vanessa S. Marsden and Christine J. Hawkins. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology, Carcinogenesis, Acta Oncologica and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.